Table 2.
Analyses of blood chemistry during probiotic intervention at week 8.
| Week 8 | C | CH | AP-32(L) | bv-77(L) | CP-9(L) | MIX(L) | AP-32(H) | bv-77(H) | CP-9(H) | MIX(H) |
|---|---|---|---|---|---|---|---|---|---|---|
| Glucose (mg/dL) |
105.6 ± 6.47 |
108.75 ± 5.91 |
106.6 ± 5.41 |
105.00 ± 5.96 |
116.6 ± 10.92 |
109.2 ± 6.30 |
99.2 * ± 4.44 |
116.6 ± 6.06 |
107.6 ± 4.62 |
107.2 ± 6.02 |
| Cholesterol (mg/dL) |
79.33 ± 6.12 |
94.50 # ± 10.43 |
77.67 * ± 10.48 |
75.67 ± 21.81 |
79.50 ± 15.18 |
72.17 * ± 15.87 |
71.83 ** ± 10.68 |
64.17 * ± 16.07 |
71.33 ** ± 7.09 |
75.00 ** ± 7.48 |
| Triacylglycerol (mg/dL) |
98.33 ± 15.16 |
129.83 # ± 22.60 |
89.33 * ± 22.47 |
104.42 ± 16.82 |
101.00 * ± 21.56 |
89.17 ** ± 18.39 |
82.50 ** ± 11.79 |
81.83 * ± 29.60 |
89.75 * ± 37.21 |
80.33 ** ± 18.68 |
| LDL (mg/dL) |
6.90 ± 1.19 |
8.13 ± 0.80 |
7.60 ± 0.89 |
7.63 ± 1.71 |
6.87 * ± 0.75 |
6.10 *** ± 0.68 |
6.52 * ± 1.26 |
6.72 * ± 0.92 |
6.22 *** ± 0.83 |
6.00 ** ± 0.89 |
| HDL (mg/dL) |
25.60 ± 2.30 |
16.22 ## ± 4.08 |
19.47 ± 4.26 |
24.57 ** ± 2.86 |
24.63 ** ± 3.24 |
25.77 ** ± 3.59 |
22.50 * ± 3.14 |
23.07 ** ± 2.93 |
23.62 ** ± 3.47 |
25.18 ** ± 2.69 |
| AST (U/L) |
118.80 ± 25.06 |
137.17 ± 19.65 |
105.00 ** ± 10.92 |
109.20 ** ± 16.58 |
107.83 * ± 17.52 |
84.67 *** ± 7.79 |
102.33 ** ± 9.33 |
88.00 *** ± 6.42 |
91.50 *** ± 10.01 |
89.83 *** ± 8.23 |
| ALT (U/L) |
33.33 ± 7.03 |
43.33 # ± 7.50 |
25.50 *** ± 4.09 |
22.83 *** ± 3.92 |
27.00 ** ± 5.40 |
28.00 ** ± 3.85 |
29.17 ** ± 4.58 |
25.83 *** ± 3.31 |
25.00 *** ± 5.55 |
28.83 ** ± 5.19 |
| Uric acid (mg/dL) |
1.37 ± 0.61 |
2.32 ## ± 0.32 |
1.38 *** ± 0.32 |
1.60 * ± 0.57 |
1.63 *** ± 0.18 |
1.77 * ± 0.47 |
1.42 ** ± 0.40 |
1.67 * ± 0.55 |
1.38 *** ± 0.30 |
1.63 ** ± 0.41 |
| Creatinine (mg/dL) |
0.31 ± 0.02 |
0.35 ± 0.07 |
0.25 * ± 0.02 |
0.26 * ± 0.04 |
0.27 * ± 0.05 |
0.26 * ± 0.04 |
0.26 * ± 0.02 |
0.24 ** ± 0.02 |
0.22 ** ± 0.04 |
0.24 ** ± 0.04 |
| Na+ (mmol/L) |
151.17 ± 1.72 |
151.17 ± 1.94 |
151.33 ± 1.37 |
153.17 ± 0.98 |
150.80 ± 1.64 |
153.33 ± 1.21 |
151.50 ± 1.64 |
152.50 ± 2.88 |
152.50 ± 0.58 |
151.40 ± 1.14 |
| K+ (mmol/L) |
6.08 ± 0.26 |
6.20 ± 0.48 |
6.45 ± 0.52 |
6.45 ± 0.51 |
6.77 ± 0.48 |
6.38 ± 0.24 |
6.70 ± 0.70 |
6.27 ± 0.41 |
6.68 ± 0.90 |
6.55 ± 0.63 |
Data are presented as the mean ± S.D. of six animals in each group. Statistical analysis was performed by using a one-way ANOVA. Statistical difference was compared between the C and CH groups (# p < 0.05, ## p < 0.01) or the CH and a probiotics-treated group (* p < 0.05, ** p < 0.01, and *** p < 0.001). C: control; CH: symptom control; MIX: probiotic mixture of AP-32, bv-77, and CP-9; L = 5 × 109 CFU/kg/day; H = 2.5 × 1010 CFU/kg/day; LDL: low-density lipoprotein; HDL: high-density lipoprotein; ALT: alanine aminotransferase, AST: aspartate Transaminase.